945528-80-3

Upstream product

• 1258946-42-7 tert-butyl 2-{[2-(tert-butoxy)-2-oxoethyl][2-bromo-3-(4-nitrophenyl)propyl]amino}acetate 

Downstream Products

• 945528-81-4 {[3-(4-aminophenyl)-2-(bis-tert-butoxycarbonylmethylamino)propyl]-[2-(bis-tert-butoxycarbonylmethylamino)propyl]amino}acetic acid tert-butyl ester 
• 945528-84-7 4-[4-(2-(bis-tert-butoxycarbonylmethylamino)-3-{[2-(bis-tert-butoxycarbonylmethylamino)propyl]-tert-butoxycarbonylmethylamino}propyl)phenylcarbamoyl]butyric acid 2,5-dioxopyrrolidin-1-yl ester 
• 945528-82-5 4-[4-(2-(bis-tert-butoxycarbonylmethylamino)-3-{[2-(bis-tert-butoxycarbonylmethylamino)propyl]-tert-butoxycarbonylmethylamino}propyl)phenylcarbamoyl]butyric acid 
• 945528-83-6 {[2-(bis-tert-butoxycarbonylmethylamino)-3-(4-isothiocyanatophenyl)propyl]-[2-(bis-tert-butoxycarbonylmethylamino)propyl]amino}acetic acid tert-butyl ester 

Relevant academic research and scientific papers

SYNTHESIS OF THERAPEUTIC AND DIAGNOSTIC DRUGS CENTERED ON REGIOSELECTIVE AND STEREOSELECTIVE RING OPENING OF AZIRIDINIUM IONS

Stereoselective and regioselective synthesis of compounds via nucleophilic ring opening reactions of aziridinium ions for use in stereoselective and regioselective synthesis of therapeutic and diagnostic compounds.

Regioselective synthesis of DTPA derivatives

The present invention provides a process for high yield regioselective synthesis of DTPA derivatives that eliminates the need for ion exchange chromotographic separation of intermediates. Moreover, as this process yields a single regioisomer of the chelat